New Antidynamic Approved

FDA Approves IncobotulinumtoxinA For Frown Lines.

Medscape (7/21, Brooks) reported that the FDA has approved "incobotulinumtoxinA (Xeomin, Merz Aesthetics)" for treating frown lines. The FDA has previously approved incobotulinumtoxinA for treating cervical dystonia and blepharospasm. Cosmetic dermatologist Oscar Hevia explained that "what is novel about incobotulinumtoxinA...is that it is free from complexing proteins and does not need refrigeration before reconstitution." It has a shelf life of up to three years, unrefrigerated. IncobotulinumtoxinA is not interchangeable with botulinim toxin products, and is contraindicated for people hypersensitive to botulinim toxin A, or suffering infections at injection sites.

http://www.bobbybukamd.com/ http://www.drbobby.com/ http://www.wbderm.com/ http://www.williamsburgderm.com/